City of Hope Publications
City of Hope’s John Zaia, M.D., will lead the development of the phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.
According to a new paper in Stem Cells Translational Medicine, the authors identify the role of a nurse qualified in both patient care and research protocols, the so-called “hybrid nurse” — a homegrown City of Hope innovation — as an important component of their success in the development of the Alpha Clinic.
Dan Rojas, 31, who has been living with HIV since 2011, is one of a handful of brave patients participating in a groundbreaking study at City of Hope that seeks a cure for AIDS.
When Christina Joseph, B.S.N., R.N., was in nursing school, a close teacher and mentor was diagnosed with cancer. “I took that as a sign,” said the Southern California native. “So I went into oncology nursing.”
Patients who have benefited from stem cell therapies funded by CIRM were the focus of the second symposium of the Alpha Stem Cell Clinics Network.
The stories of patients who have benefited from stem cell therapies funded by the California Institute for Regenerative Medicine (CIRM) were the focus of the second symposium of the institute’s Alpha Stem Cell Clinics Network.
Linda Malkas, Ph.D., who holds the M.T. & B.A. Ahmadinia Professorship in Molecular Oncology, has been appointed to the governing board of CIRM, the state’s stem cell agency.
The stories of patients who have benefited from stem cell therapies funded by CIRM will be highlighted at the second symposium of the institute’s Alpha Stem Cell Clinics Network at City of Hope.
City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR T cells dramatically improved quality of life for patient with recurrent glioblastoma.
A brain tumor patient is the first to be treated by City of Hope’s Alpha Clinic for Cell Therapy and Innovation, part of the state’s Alpha Clinics network, created to speed the development and delivery of stem cell therapies to patients who desperately need them.
Now, as City of Hope officially opens the Alpha Clinic for Cell Therapy and Innovation, patients battling cancer and other life-threatening diseases have another option: stem cell-based therapy.
Grant will enable scientists to adapt current cell culture techniques to a more scalable and controllable system that reflects GMP. Innovative platform will allow larger scale production and storage of stem cells.
Physicians and scientists at the Hematologic Malignancies and Stem Cell Transplantation Institute are using T cell therapy against blood cancers and other diseases.
Identifying cures for currently incurable diseases and providing patients safe, fast, and potentially life-saving treatments is the focus of City of Hope’s new Alpha Clinic for Cell Therapy and Innovation (ACT-I).
Symposium of the CIRM Alpha Stem Cell Clinics Network
- Welcome Address
- Introduction of Morning Sessions
- Keynote Address I: CIRM's Role in Advancing Stem Cell-Based Therapies
- Stem Cell Therapy: Value and Reimbursement Considerations
- All in: Turning the Alpha Clinic Vision into a Reality for Patients
- Retinal Progenitor Cells for Treatment of Retinitis Pegmentosa
- Second Vision: A Light at the End of the Tunnel
- Corneal Regeneration: Now and Beyond
- Keynote Address II: Removing Stakeholder Barriers to Stem Cell Therapy
- Cancer Stem Cell Targeting with Cirmtuzumab
- Oncternal Therapeutics and the Promise of Cancer Stem Cell Therapy
- Clinical Observations from the Phase 1 Trial of Cirmtuzumab
- Novel Education: We Give Patients What They Want in Trials - iPad
- Bringing Patients, Industry, Principal Investigators and Regulators Together
- CAR T Cell Therapy: Challenges and Lessons Learned
- Clinical Trial of IL13r-CAR T Cells for Glioblastoma
- Considerations and Strategies for Bringing T Cell Products to the Market
- The Center for Biomedicine and Genetics: A Biological Forge
- Keynote Address III: The Public's Role in Advancing Stem Cell-based Therapies
- Negotiating Global Regulatory Pathways for Cell Based Therapies
- What it Will Take to Bring Stem Cell Gene Therapy to All Who Can Benefit From It
- Model Roundtable: The Alpha Clinics and the Future
- The Shape of Things to Come-Stem Cells and the Lives of Real People